Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CLDI
CLDI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CLDI News
Calidi Biotherapeutics Announces Financial Results and Key Operational Updates for Q3 2025
Nov 13 2025
Newsfilter
Calidi Biotherapeutics Completes $6.9 Million Public Offering with Full Over-Allotment Option Exercised by Underwriters
Aug 21 2025
Newsfilter
Nasdaq Declines 1%; Lowe's Reports Positive Earnings
Aug 20 2025
Benzinga
Dow Rises by 100 Points; Target Stock Declines Following Q2 Earnings Report
Aug 20 2025
Benzinga
Calidi Biotherapeutics Reveals Pricing for $6 Million Underwritten Public Offering
Aug 20 2025
Newsfilter
Calidi Loss Down 23 Percent in Fiscal Q2
Aug 08 2025
NASDAQ.COM
Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights
Aug 08 2025
Newsfilter
Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights
Aug 08 2025
Yahoo Finance
Upcoming Stock Splits This Week (August 4 to August 8) – Stay Invested
Aug 04 2025
TipRanks
Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma
Jul 29 2025
Newsfilter
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025
Jul 25 2025
Newsfilter
Calidi announces reverse stock split, expected to begin trading on a 1-for-12 split adjusted basis
Jul 25 2025
SeekingAlpha
3 Penny Stocks to Watch Now, 7/10/25
Jul 10 2025
TipRanks
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up
Jul 10 2025
Newsfilter
Crude Oil Moves Higher; RxSight Shares Plunge
Jul 09 2025
Benzinga
Dow Jumps 200 Points; US Wholesale Inventories Fall 0.3% In May
Jul 09 2025
Benzinga
Show More News
